Abstract
The aim of the study is to evaluate the frequency and features of positive pathergy test (PPT) in Italy, its role in the diagnosis of Behçet’s disease (BD), and any association with other BD-related manifestations. 52 BD patients, 52 patients with axial spondyloarthritis (ax-SpA), and 26 healthy controls (HCs) underwent intradermal injection of normal saline and intradermal needle soaked with fresh self-saliva. The results of pathergy tests were statistically analysed in the light of demographic, clinical, and therapeutic features of subjects enrolled. Pathergy test performed with saline resulted always negative in all groups. Skin prick test using self-saliva resulted in the occurrence of a papule in 3 (5.8%) BD patients and in 1 (1.9%) patient with ax-SpA. A ≥ 15 mm erythematous area surrounding the needle prick site was observed in 22 (42.3%) BD patients, 5 (9.6%) patients with ax-SpA, and 2 (7.7%) HCs (p = 0.00002). The frequency of skin erythema was significantly more frequent in patients with BD than those with ax-SpA (p < 0.0001) and HCs (p = 0.003). No statistically significant differences were observed between ax-SpA patients and HCs (p = 1.000). The occurrence of skin erythema at pathergy test was not associated with any BD-related clinical manifestation. Erythema at self-saliva prick test presented a sensitivity of 42.31% (CI 28.73–56.80%) and a specificity of 91.03% (CI 82.38–96.32%). The development of a ≥ 15 mm erythematous area at self-saliva prick test could be sufficient to unveil the hyper-reactivity of the innate immune system in BD patients from Western Europe, where the development of skin erythema shows good sensitivity and specificity toward the diagnosis of BD.
Similar content being viewed by others
Change history
05 August 2023
A Correction to this paper has been published: https://doi.org/10.1007/s11739-023-03382-w
References
Vitale A, Rigante D, Lopalco G, Emmi G, Bianco MT, Galeazzi M, Galeazzi M, Iannone F, Cantarini L (2016) New therapeutic solutions for Behçet’s syndrome expert. Opin Investig Drugs 25:827–840. https://doi.org/10.1080/13543784.2016.1181751
Yazici Y, Hatemi G, Bodaghi B, Cheon JH, Suzuki N, Ambrose N, Yazici H (2021) Behçet syndrome. Nat Rev Dis Primers 7:67. https://doi.org/10.1038/s41572-021-00301-1
Criteria for diagnosis of Behçet’s disease (1990) International Study group for Behçet’s disease. Lancet 335:1078–1080
International Team for the Revision of the International Criteria for Behçet’s Disease (ITR-ICBD) (2014) The International Criteria for Behçet’s disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol 28:338–347. https://doi.org/10.1111/jdv.12107
Gül A, Esin S, Dilsen N, Koniçe M, Wigzell H, Biberfeld P (1995) Immunohistology of skin pathergy reaction in Behçet’s disease. Br J Dermatol 132:901–907. https://doi.org/10.1111/j.1365-2133.1995.tb16946.x
Sequeira FF, Daryani D (2011) The oral and skin pathergy test. Indian J Dermatol Venereol Leprol 77:526–530. https://doi.org/10.4103/0378-6323.82399
Dilşen N, Koniçe M, Aral O, Ocal L, Inanç M, Gül A (1993) Comparative study of the skin pathergy test with blunt and sharp needles in Behçet’s disease: confirmed specificity but decreased sensitivity with sharp needles. Ann Rheum Dis 52:823–825. https://doi.org/10.1136/ard.52.11.823
Davatchi F, Shahram F, Chams C, Chams H, Nadji A (2005) Behçet’s Disease. Acta Med Iran 43:233–242
Togashi A, Saito S, Kaneko F, Nakamura K, Oyama N (2011) Skin prick test with self-saliva in patients with oral aphthoses: a diagnostic pathergy for Behcet’s disease and recurrent aphthosis. Inflamm Allergy Drug Targets 10:164–170. https://doi.org/10.2174/187152811795564109
Sieper J, Rudwaleit M, Baraliakos X, Brandt J, Braun J, Burgos-Vargas R, Dougados M, Hermann KG, Landewé R, Maksymowych W, van der Heijde D (2009) The Assessment of spondyloarthritis international society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis. https://doi.org/10.1136/ard.2008.104018
Shenavandeh S, Sadeghi SMK, Aflaki E (2021) Pathergy test with a 23G needle with and without self-saliva in patients with Behçet’s disease, recurrent aphthous stomatitis and control group compared to the 20G test. Reumatologia 59:302–308. https://doi.org/10.5114/reum.2021.110567
Varol A, Seifert O, Anderson CD (2010) The skin pathergy test: innately useful? Arch Dermatol Res 302:155–168. https://doi.org/10.1007/s00403-009-1008-9
Lawton G, Bhakta BB, Chamberlain MA, Tennant A (2004) The Behcet’s disease activity index. Rheumatology (Oxford) 43:73–78. https://doi.org/10.1093/rheumatology/keg453
Davatchi F, Chams-Davatchi C, Ghodsi Z, Shahram F, Nadji A, Shams H, Akhlaghi M, Larimi R, Sadeghi-Abdolahi B (2011) Diagnostic value of pathergy test in Behcet’s disease according to the change of incidence over the time. Clin Rheumatol 30:1151–1155. https://doi.org/10.1007/s10067-011-1694-5
Yazici H, Chamberlain MA, Tüzün Y, Yurdakul S, Müftüoglu A (1984) A comparative study of the pathergy reaction among turkish and british patients with Behçet’s disease. Ann Rheum Dis 43:74–75. https://doi.org/10.1136/ard.43.1.74
Mahr A, Belarbi L, Wechsler B, Jeanneret D, Dhote R, Fain O, Lhote F, Ramanoelina J, Coste J, Guillevin L (2008) Population-based prevalence study of Behçet’s disease: differences by ethnic origin and low variation by age at immigration. Arthritis Rheum 58:3951–3959. https://doi.org/10.1002/art.24149
Bergamo S, di Meo N, Stinco G, Bonin S, Trevisini S, Trevisan G (2017) Adamantiades-Behçet disease at the beginning of the silk route: north-east italian experience. Acta Dermatovenerol Croat 25:295–297
Leccese P, Yazici Y, Olivieri I (2017) Behcet’s syndrome in nonendemic regions. Curr Opin Rheumatol 29:12–16. https://doi.org/10.1097/BOR.0000000000000349
Askari A, Al-Aboosi M, Sawalha A (2000) Evaluation of pathergy test in north jordan. Clin Rheumatol 19:249–251. https://doi.org/10.1007/s100670050170
Moll JM, Haslock I, Macrae IF, Wright V (1974) Associations between ankylosing spondylitis, psoriatic arthritis, Reiter’s disease, the intestinal arthropathies, and Behcet’s syndrome. Medicine (Baltimore) 53:343–364. https://doi.org/10.1097/00005792-197409000-00002
McGonagle D, Aydin SZ, Gül A, Mahr A, Direskeneli H (2015) ’MHC-I-opathy’-unified concept for spondyloarthritis and Behçet disease. Nat Rev Rheumatol 11:731–740. https://doi.org/10.1038/nrrheum.2015.147
Vitale A, Rigante D, Lopalco G, Selmi C, Galeazzi M, Iannone F, Cantarini L (2016) Interleukin-1 Inhibition in Behçet’s disease. Isr Med Assoc J 18:171–176
Mauro D, Thomas R, Guggino G, Lories R, Brown MA, Ciccia F (2021) Ankylosing spondylitis: an autoimmune or autoinflammatory disease? Nat Rev Rheumatol 17:387–404. https://doi.org/10.1038/s41584-021-00625-y
Hsieh J, Kadavath S, Efthimiou P (2014) Can traumatic injury trigger psoriatic arthritis? a review of the literature. Clin Rheumatol 33:601–608. https://doi.org/10.1007/s10067-013-2436-7
Camargo CM, Brotas AM, Ramos-e-Silva M, Carneiro S (2013) Isomorphic phenomenon of Koebner: facts and controversies. Clin Dermatol 31:741–749. https://doi.org/10.1016/j.clindermatol.2013.05.012
Kalay Yildizhan İ, Boyvat A (2019) Diagnostic sensitivity of different applications of pathergy test for Behçet’s disease. Arch. Rheumatol. 35:29–34. https://doi.org/10.5606/ArchRheumatol.2020.7380
Assar S, Sadeghi B, Davatchi F, Ghodsi SZ, Nadji A, Shahram F, Ashofte F, Larimi SR, Sadeghi M (2017) The association of pathergy reaction and active clinical presentations of Behçet’s disease. Reumatologia 55:79–83. https://doi.org/10.5114/reum.2017.67602
Alli N, Gur G, Yalcin B, Hayran M (2009) Patient characteristics in Behçet disease: a retrospective analysis of 213 Turkish patients during 2001–4Am. J Clin Dermatol 10:411–418. https://doi.org/10.2165/11310880-000000000-00000
Krause I, Molad Y, Mitrani M, Weinberger A (2000) Pathergy reaction in Behçet’s disease: lack of correlation with mucocutaneous manifestations and systemic disease expression. Clin Exp Rheumatol 18:71–74
Davies PG, Fordham JN, Kirwan JR, Barnes CG, Dinning WJ (1984) The pathergy test and Behçet’s syndrome in Britain. Ann Rheum Dis 43:70–73. https://doi.org/10.1136/ard.43.1.70
Gürler A, Boyvat A, Türsen U (1997) Clinical manifestations of Behçet’s disease: an analysis of 2147 patients. Yonsei Med J 38:423–427. https://doi.org/10.3349/ymj.1997.38.6.423
Al-Rawi ZS, Sharquie KE, Khalifa SJ, Al-Hadithi FM, Munir JJ (1986) Behçet’s disease in Iraqi patients. Ann Rheum Dis 45:987–990. https://doi.org/10.1136/ard.45.12.987
Chang HK, Cheon KS (2002) The clinical significance of a pathergy reaction in patients with Behcet’s disease. J Korean Med Sci 17:371–374. https://doi.org/10.3346/jkms.2002.17.3.371
Akmaz O, Erel A, Gürer MA (2000) Comparison of histopathologic and clinical evaluations of pathergy test in Behçet’s disease. Int J Dermatol 39:121–125. https://doi.org/10.1046/j.1365-4362.2000.00884.x
Kutlubay Z, Tüzün Y, Wolf R (2017) The Pathergy test as a diagnostic tool. Skinmed 1(15):97–104
Vitale A, Della Casa F, Ragab G, Almaghlouth IA, Lopalco G, Pereira RM, Guerriero S, Govoni M, Sfikakis PP, Giacomelli R, Ciccia F, Monti S, Ruscitti P, Piga M, Lomater C, Tufan A, Opris-Belinski D, Emmi G, Hernández-Rodríguez J, Şahin A, Sebastiani GD, Bartoloni E, Akkoç N, Gündüz ÖS, Cattalini M, Conti G, Hatemi G, Maier A, Parronchi P, Del Giudice E, Erten S, Insalaco A, Li Gobbi F, Maggio MC, Shahram F, Caggiano V, Hegazy MT, Asfina KN, Morrone M, Prado LL, Dammacco R, Ruffilli F, Arida A, Navarini L, Pantano I, Cavagna L, Conforti A, Cauli A, Marucco EM, Kucuk H, Ionescu R, Mattioli I, Espinosa G, Araújo O, Karkaş B, Canofari C, Sota J, Laymouna AH, Bedaiwi AA, Colella S, Giardini HAM, Albano V, Lo Monaco A, Fragoulis GE, Kardas RC, Berlengiero V, Hussein MA, Ricci F, La Torre F, Rigante D, Więsik-Szewczyk E, Frassi M, Gentileschi S, Tosi GM, Dagostin MA, Mahmoud AAA, Tarsia M, Alessio G, Cimaz R, Giani T, Gaggiano C, Iannone F, Cipriani P, Mourabi M, Spedicato V, Barneschi S, Aragona E, Balistreri A, Frediani B, Fabiani C, Cantarini L, Alliance AD, (AIDA) Network, (2022) Development and implementation of the AIDA international registry for patients with Behçet’s disease. Intern Emerg Med. https://doi.org/10.1007/s11739-022-03038-1
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical statements
The study has been approved by the local Ethics Committee of Azienda Ospedaliera Universitaria Senese, Siena, Italy (AIDA Project; Ref. No.14,951). The study protocol conformed to the tenets of the Declaration of Helsinki; informed consent was obtained from all patients and HC enrolled.
Human and animal rights statement and Informed consent
Informed consent was obtained from all patients and healthy controls enrolled; animals have not been included in the present study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The original online version of this article was revised: In this article the author name is wrongly mentioned Vitale Antonio instead of Antonio Vitale. It has been corrected.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Vitale, A., Berlengiero, V., Caggiano, V. et al. The diagnostic role of pathergy test in patients with Behçet’s disease from the Western Europe. Intern Emerg Med 18, 77–83 (2023). https://doi.org/10.1007/s11739-022-03117-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-022-03117-3